Journal Article

DKFZ-2021-02067

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Dietary Advanced Glycation End-Products and Colorectal Cancer Risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) Study.

Aglago, E. K. ; Mayén, A.-L. ; Knaze, V. ; Freisling, H. ; Fedirko, V. ; Hughes, D. J. ; Jiao, L. ; Eriksen, A. K. ; Tjønneland, A. ; Boutron-Ruault, M.-C. ; Rothwell, J. A. ; Severi, G. ; Kaaks, R.DKFZ* ; Katzke, V.DKFZ* ; Schulze, M. B. ; Birukov, A. ; Palli, D. ; Sieri, S. ; Santucci de Magistris, M. ; Tumino, R. ; Ricceri, F. ; Bueno-de-Mesquita, B. ; Derksen, J. W. G. ; Skeie, G. ; Gram, I. T. ; Sandanger, T. ; Quirós, J. R. ; Luján-Barroso, L. ; Sánchez, M.-J. ; Amiano, P. ; Chirlaque, M.-D. ; Gurrea, A. B. ; Johansson, I. ; Manjer, J. ; Perez-Cornago, A. ; Weiderpass, E. ; Gunter, M. J. ; Heath, A. K. ; Schalkwijk, C. G. ; Jenab, M.

2021
MDPI Basel

This record in other databases:  

Please use a persistent id in citations: doi:10.3390/nu13093132

Abstract: Dietary advanced glycation end-products (dAGEs) have been hypothesized to be associated with a higher risk of colorectal cancer (CRC) by promoting inflammation, metabolic dysfunction, and oxidative stress in the colonic epithelium. However, evidence from prospective cohort studies is scarce and inconclusive. We evaluated CRC risk associated with the intake of dAGEs in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Dietary intakes of three major dAGEs: Nε-carboxy-methyllysine (CML), Nε-carboxyethyllysine (CEL), and Nδ-(5-hydro-5-methyl-4-imidazolon-2-yl)-ornithine (MG-H1) were estimated in 450,111 participants (median follow-up = 13 years, with 6162 CRC cases) by matching to a detailed published European food composition database. Hazard ratios (HRs) and 95% confidence intervals (CIs) for the associations of dAGEs with CRC were computed using multivariable-adjusted Cox regression models. Inverse CRC risk associations were observed for CML (HR comparing extreme quintiles: HRQ5vs.Q1 = 0.92, 95% CI = 0.85-1.00) and MG-H1 (HRQ5vs.Q1 = 0.92, 95% CI = 0.85-1.00), but not for CEL (HRQ5vs.Q1 = 0.97, 95% CI = 0.89-1.05). The associations did not differ by sex or anatomical location of the tumor. Contrary to the initial hypothesis, our findings suggest an inverse association between dAGEs and CRC risk. More research is required to verify these findings and better differentiate the role of dAGEs from that of endogenously produced AGEs and their precursor compounds in CRC development.

Keyword(s): advanced glycation end-products ; colorectal cancer ; dietary exposure ; dietary glycation compounds

---

Contributing Institute(s):

1. C020 Epidemiologie von Krebs (C020)

Research Program(s):

1. 313 - Krebsrisikofaktoren und Prävention (POF4-313) (POF4-313)

Appears in the scientific report 2021

---

Database coverage:
; ; ; Article Processing Charges ; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; DOAJ Seal ; Essential Science Indicators ; Fees ; IF < 5 ; JCR ; PubMed Central ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection

---